Triple positive breast cancer (TPBC) is one of the most aggressive breast cancer. Due to the
unique cell phenotype, aggressiveness, metastatic potential and lack of receptors or targets …

Over the past several decades, liposomes have been extensively developed and used for
various clinical applications such as in pharmaceutical, cosmetic, and dietetic fields, due to …

Doxorubicin is one of the most effective chemotherapeutic agents; however, it has various
side effects, such as cardiotoxicity. Therefore, novel methods are needed to reduce its …

Our research aimed to enhance the oral bioavailability of doxorubicin hydrochloride (DOX·
HCl) while minimizing the potential for myocardial toxicity. To achieve this goal, we …

Recent developments in the field of nanomedicine have introduced a wide variety of
nanomaterials that are capable of recognizing and killing tumor cells with increased …

Introduction The resistance to chemotherapy is a significant hurdle in breast cancer
treatment, prompting the exploration of innovative strategies. This review discusses the …

Osteosarcoma (OS) is a common malignant bone tumor that occurs mostly in children and
adolescents. At present, surgery after chemotherapy or postoperative adjuvant …

Nanomedicines are potentially useful for targeted cancer chemotherapy; however, it is
difficult to design nanomedicines with controllable structures and functions to overcome a …

Breast cancer (BC) is a heterogenous disease, with prognosis and treatment options
depending on Estrogen, Progesterone receptor, and Human Epidermal Growth Factor …

Chemotherapy together with surgery and/or radiotherapy are the most common therapeutic
methods for treating cancer. However, the off-target effects of chemotherapy are known to …